Evidence map›Paper›PMID 32885098›Full record

ArticleNanoImpact2020

Comparison of

Yifang Wang, Andrea Adamcakova-Dodd, Benjamin R Steines, Xuefang Jing, Aliasger K Salem, Peter S Thorne

Open access · greenAbstract read
In one paragraph

Article in NanoImpact, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. HumanTissue barriers · 2024
    Review
  4. On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI).European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yifang WangHuman Toxicology Interdisciplinary Program, University of Iowa, Iowa City, IA, USA.
Andrea Adamcakova-DoddOccupational and Environmental Health, University of Iowa, Iowa City, IA, USA.
Benjamin R SteinesOccupational and Environmental Health, University of Iowa, Iowa City, IA, USA.
Xuefang JingOccupational and Environmental Health, University of Iowa, Iowa City, IA, USA.
Aliasger K SalemCollege of Pharmacy, University of Iowa, Iowa City, IA, USA.
Peter S ThorneHuman Toxicology Interdisciplinary Program, University of Iowa, Iowa City, IA, USA.
University of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Engineered Nanomaterial Synthesis, Characterization and Method Development Center for Nano-safety ResearchU24ES026946 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEMOKRITOU, PHILIP · 2016 to 2020
$3.8M
Immunomodulation Potential of Inhaled Engineered Nanomaterials as an Adverse Outcome PathwayU01ES027252 · NIEHS · UNIVERSITY OF IOWA · PI THORNE, PETER S · 2016 to 2020
$2.1M
NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605NIEHS NIH HHS U01 ES027252NIEHS NIH HHS U24 ES026946
6 · The paper itself

Abstract

Airborne engineered nanomaterials (ENMs) can readily enter the human body through inhalation potentially leading to adverse health effects such as cardiovascular and pulmonary diseases. Our group has previously utilized and validated an integrated low flow system capable of generating and depositing airborne ENMs directly onto cells at an air-liquid interface (ALI). To further improve this ALI method for an even closer representation of the

Indexed as

A549Air interfaced cultureAir-liquid interfaceCo-cultureEA.hy 926In vitro toxicologyNanoparticlesTHP-1

Identifiers

PMID32885098
PMCPMC7462419
OpenAlexW3008531455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.